Spinal cord regenerative therapy based on transplantation of canine bone marrow stromal cells (BMSCs) has recently been clinically applied for treatment of severe spinal cord injury (SCI) in dogs \[[@r17], [@r18]\]. Generally, utilization of autologous BMSCs requires expansion of these cells in culture, which is why at least 1--3 weeks are necessary between the time of bone marrow collection and transplantation \[[@r17]\]. An effective long-term preservation technique for canine BMSCs that would maintain cell functions and properties is critical for the timely transplantation of an adequate number of autologous canine BMSCs in dogs with SCI.

The most common and widely used method for the long-term preservation of living cells is cryopreservation. However, stem cells, including BMSCs, are sensitive to freezing and can be damaged by the external and/or intracellular ice crystal formation; the survival rate of cryopreserved stem cells after thawing could therefore be significantly decreased \[[@r4], [@r5]\]. Currently, there have been only a few basic researches on cryopreservation of canine BMSCs. In the present study, we investigated the cell viability and proliferative capacity of cryopreserved canine BMSCs after thawing.

Cryoprotectant solutions containing dimethyl sulfoxide (DMSO) are frequently used for cryopreservation of stem cells \[[@r5], [@r12], [@r16]\]. However, DMSO can be also cytotoxic and may affect the stem cell capacity for proliferation and differentiation after thawing \[[@r3], [@r5], [@r13], [@r20]\]. In the present study, we therefore compared the effects of cryoprotectant solutions with or without DMSO on the proliferation and neuronal differentiation of canine BMSCs.

The present study was conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals of the College of Bioresource Sciences of Nihon University. Three healthy adult beagles were used for BMSC isolation performed as previously described \[[@r2]\]. Briefly, bone marrow was collected from the humerus under general anesthesia, and mononuclear cells were obtained after separation by density gradient centrifugation using a Histopaque-1077 (Sigma-Aldrich, St. Louis, MO, U.S.A.). The mononuclear cells were transferred to two 25-cm^2^ culture flasks and statically cultured in α-modified Eagle's minimum essential medium (α-MEM; Invitrogen, Carlsbad, CA, U.S.A.) supplemented with 10% fetal bovine serum (FBS; Invitrogen) at 5% CO~2~ and 37°C. Non-adherent cells were removed by aspiration, and the attached canine BMSCs were cultured until almost reached confluency and collected using 0.25% trypsin-EDTA (Invitrogen).

Canine BMSCs were cryopreserved using cryoprotectant solutions with 10% DMSO and 10% FBS (DF group: n=6) or without DMSO and FBS (Cellvation^®^; Celox Laboratories, St. Paul, MN, U.S.A.) (DF-free group: n=6). Cells (1.0 × 10^6^) were resuspended in 1 m*l* of cryoprotectant solution within a cryogenic vial (Sumitomo Bakelite, Tokyo, Japan) and placed in a biofreezing vessel (BICELL^®^; Nihon Freezer, Tokyo, Japan) for cryopreservation at −80°C in a freezer without programmed decrease in temperature. After 7 days of cryopreservation, vials were removed from the biofreezing vessel and immersed in a water bath at 37°C for 1 min. Fresh canine BMSCs at the second passage were used as a control (n=6). Cell viability was assessed by trypan-blue exclusion in the DF and DF-free groups immediately after thawing and in the control group at the passage. In the DF group, cryopreserved cells were washed twice with α-MEM containing 10% FBS before culture. Cells were seeded in 6-well plates at a density of 1 × 10^4^ cells/well and cultured in α-MEM containing 10% FBS; cell morphology was evaluated in cultures using an inverted microscope. Adherent cells were collected at days 2, 4, 6, 8, 10 and 12 of culture by dissociation with 0.25% trypsin-EDTA and counted to assess proliferative capacity.

Neuronal differentiation of canine BMSCs was induced by use of the method described by Woodbury *et al.* \[[@r21]\]. After 3 days of culture, the medium was changed to low-glucose Dulbecco's modified Eagle's medium (DMEM; Invitrogen) supplemented with 20% FBS and 1 mM β-mercaptoethanol (BME; Sigma-Aldrich). After 24 hr of culturing in this medium, differentiation into neurons was induced using low-glucose DMEM with 2% DMSO and 200 *µ*M butylated hydroxyanisole (BHA; Sigma-Aldrich), and morphological changes were evaluated by microscopy. After 6 hr of neuronal induction, cells were fixed in 10% buffered formalin solution and reacted with the anti-human neurofilament light chain (NF-L) protein monoclonal antibody (Clone No. 2F11, Thermo Fisher Scientific Inc., Rockford, IL, U.S.A.) and anti-bovine microtubule-associated protein 2 (MAP-2) monoclonal antibody (Clone No. AP20, Millipore, Billerca, MA, U.S.A.) used as neuronal makers.

Total RNA was extracted from canine BMSCs using TRIzol (Invitrogen) before and 6 hr after neuronal induction. The first-strand cDNA was synthesized using the PrimeScript RT Master Mix (Takara, Otsu, Japan). Quantitative PCR was performed with primers specific for genes expressed by neural stem/progenitor cells and neurons ([Table 1](#tbl_001){ref-type="table"}Table 1.Primers canine specific for neural stem/progenitor cell and neuron markersGene symbolProteinSequenceMarker*GUSB*Glucuronidase βF: ACATCGACGACATCACCGTCAHousekeeping geneR: GGAAGTGTTCACTGCCCTGGA*SOX-2*Sex determining region Y-box 2F: ATGCACCGCTACGACGTGANeural stem/progenitor cellR: TGCTGCGAGTAGGACATGCTG*NES*NestinF: GGACGGGCTTGGTGTCAATAGR: AGACTGCTGCAGCCCATTCA*POU5F1*Oct-3/4F: TGCCAAGCTCCTGAAGCAGAR: AAACTGAGCTGCAGAGCCTCAA*MAP-2*Microtubule-associated protein 2F: AAGCATCAACCTGCTCGAATCCNeuronR: GCTTAGCGAGTGCAGCAGTGAC*NEFL*Neurofilament light chainF: TGAATATCATGGGCAGAAGTGGAAR: GGTCAGGATTGCAGGCAACA). The thermal cycler was programmed to incubate initial denaturation for 30 sec at 95°C and then to proceed with 40 cycles of primer annealing for 5 sec at 95°C and primer extension for 30 sec at 60°C. The results were analyzed by the second derivative method and ΔΔCt method using TP900 DiceRealTime v4.02B (Takara). Glucuronidase β (*GUSB*) was used as an endogenous control, and the amplification of the control group was used for calibration.

Statistical analysis of the data was performed using the StatMate IV software package (ATMS, Tokyo, Japan). The data were analyzed by two-way analysis of variance (ANOVA) among the groups, and Tukey's test was used as the post-hoc test. Paired student *t*-test was performed to compare the data before and after neuronal induction. The data are presented as means ± standard errors; *P* values less than 0.05 are considered significant.

The morphology of canine BMSCs in the DF and DF-free groups immediately after thawing was similar to that in the control group. No significant differences in cell numbers were observed between before and after cryopreservation in the DF and DF-free groups. The cell viability in the DF-free group (99.0 ± 0.9%) was higher than in the DF group (89.7 ± 3.0%) and almost the same as in the control group (100%). Proliferation of fibroblast-like cells was observed in both DF and DF-free groups. But, while the proliferative capacity in the DF-free group was similar to that in the control group, it was lower in the DF group despite morphological similarity of the cells in all the groups ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Morphology of canine bone marrow stromal cells (BMSCs) in the DF (A), DF-free (B) and control (C) groups. (D) The proliferative capacity of canine BMSCs in the DF (closed triangles), DF-free (closed boxes) and control (closed circles) groups.).

After neuronal induction, cryopreserved canine BMSCs in both the DF and DF-free groups developed neuron-like morphology ([Fig. 2A and 2B](#fig_002){ref-type="fig"}Fig. 2.Morphology of canine BMSCs in the DF (A), DF-free (B) and control (C) groups at 6 hr after neuronal induction. Canine BMSCs developed neuron-like morphology in all groups. Scale bars=60 *µ*m (A--C). Immunocytochemical staining of neuron-like cells in the DF (D, G), DF-free (E, H) and control (F, I) groups; these neuron-like cells were positive for MAP-2 (D--F) and neurofilament-L (G--I). Scale bars=30 *µ*m (D--I). The mRNA expression levels of *MAP-2*(J) and *NEFL*(K) before (pre) and 6 hr after (post) neuronal induction. (J) Significant increases were detected in all groups (\*: *P*\<0.05, †: *P*\<0.01, ††: *P*\<0.001).), and nearly all neuron-like cells stained positive for NF-L and MAP-2 ([Fig. 2D, 2E, 2G and 2H](#fig_002){ref-type="fig"}), similar to the control group ([Fig. 2C, 2F and 2I](#fig_002){ref-type="fig"}). The positive ratio of NF-L or MAP-2 was approximately 90% in each group, and no significant differences in the ratio were observed among the groups. Cryopreserved canine BMSCs expressed mRNA of sex determining region Y-box 2 (*SOX-2*), nestin (*NES*) and POU domain transcription factor 1 (*POU5F1*) genes for neural stem/progenitor cell makers after thawing, and no significant differences were observed between the DF and DF-free groups. Upon neuronal induction, the mRNA expression levels for *MAP-2* were significantly increased in all groups ([Fig. 2J](#fig_002){ref-type="fig"}). *MAP-2* mRNA expression level after neuronal induction in the DF-free group was significantly higher than in the DF and control groups ([Fig. 2J](#fig_002){ref-type="fig"}). The mRNA expression levels for neurofilament-L polypeptide (*NEFL*) were also increased after neuronal induction in all groups ([Fig. 2K](#fig_002){ref-type="fig"}).

In the present study, cryopreserved canine BMSCs demonstrated high cell viability and proliferative capacity after thawing and expressed mRNA for stem cell makers. These results suggest that cryopreservation of canine BMSCs using this method might not affect these capacities and expressions. To the best of our knowledge, neuronal differentiation potential of cryopreserved canine BMSCs has not been previously investigated. In the present study, we showed that upon neuronal induction, the cryopreserved canine BMSCs acquired neuron-like morphology and stained positive for neuronal marker MAP-2 and NF-L; in addition, the mRNA expression levels for neuronal markers *MAP-2* and *NEFL* were increased. These results suggest that cryopreserved canine BMSCs with this method might have the capacity to differentiate into a neuronal lineage.

In the present study, the positive ratios of neuron markers were approximately 90% after neuronal induction in each group, and these results were similar to other and our previous *in vitro* studies using the same neural induction protocol \[[@r2], [@r14], [@r21]\]. However, the ratio of the cells that changed to the neuron-like morphology was much lower than the positive ratios of neuron markers. It has been reported that BMSCs are not composed of a single cell type but of crude heterogenous cell populations and *in vivo* differentiation potential of BMSCs into neuron is generally low \[[@r8]\]. From these reasons, it is questionable whether approximately 90% of cryopreseved canine BMSCs differentiate into functional, mature neurons *in vivo*. In addition, Lu *et al.* suggested that the morphological changes and immunocytochemistry were simply artifacts after using chemical induction with BME and BHA to induce the development of rat BMSCs into neurons \[[@r14]\]. Therefore, additional investigations using electrophysiological techniques should be performed to prove that cryopreserved canine BMSCs are able to differentiate into functional, mature neurons. Further investigations, including *in vivo* experiments, will also be needed, before cryopreserved canine BMSCs are clinically applied to dogs with SCI.

The selection of an optimal cryoprotectant and freezing method is the key to the successful cryopreservation of canine BMSCs. There have been few reports on the cryopreservation of canine BMSCs \[[@r10], [@r11]\]. In those studies, a cryoprotectant solution containing 10% DMSO and 10% FBS or newborn calf serum was used \[[@r10], [@r11]\]. However, DMSO showed both cytotoxicity and neurological toxicity \[[@r3], [@r5], [@r6], [@r13], [@r20]\], and FBS could cause bovine-derived infectious diseases and heteroantigen-induced immune reactivity. It is thus important to develop a cryoprotectant solution without DMSO and/or FBS for the cryopreservation of canine BMSCs. Our results demonstrate that the cell viability and proliferative capacity of canine BMSCs in the DF-free group were superior to those in the DF group. Furthermore, upon neuronal induction, *MAP-2* mRNA expression in the DF-free group was significantly higher than in the DF group. The DMSO/FBS-free cryoprotectant solution used in this study may be beneficial for cryopreservation of canine BMSCs for subsequent use in spinal cord regenerative therapy.

Another problem in the cryopreservation of stem cells is that costly equipment and complicated procedures are usually required. Simple methods must be established in order to popularize the cryopreservation of canine BMSCs in a clinical setting. BMSCs are commonly frozen using a programmable freezer or multi-step freezing procedure \[[@r7], [@r10], [@r11]\]. In the present study, instead of a programmable freezer, we used a biofreezing vessel, which ensured slow freezing. The cooling rate of the biofreezing vessel used in the present study is approximately −1.0°C/min, and the biofreezing vessel is able to provide an environment similar to a programmable freezer \[[@r9], [@r19]\]. Several studies have documented that conventional controlled-rate freezing and storage in liquid nitrogen are not absolutely necessary for a successful cryopreservation of human progenitor cells and could be replaced by storage at −80°C in a mechanical freezer \[[@r1], [@r15]\]. The biofreezing vessel used in this study is designed to be able to store the cells at −80°C. In our case, the biofreezing vessel was placed in a deep freezer, a very simple procedure that does not require specialized equipment, although further investigations including the effects of long-term cryopreservation are necessary.

In conclusion, cryopreservation showed no significant adverse effects on the cell viability, proliferative capacity and differentiation potential into a neuronal lineage of canine BMSCs. Our cryopreservation method using DF-free cryoprotectant solution and a biofreezing vessel may be very useful for cryopreservation of canine BMSCs and subsequent spinal cord regenerative therapy in dogs.
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